EA202190201A1 - Составы для уменьшения размера опухоли и способы их применения - Google Patents
Составы для уменьшения размера опухоли и способы их примененияInfo
- Publication number
- EA202190201A1 EA202190201A1 EA202190201A EA202190201A EA202190201A1 EA 202190201 A1 EA202190201 A1 EA 202190201A1 EA 202190201 A EA202190201 A EA 202190201A EA 202190201 A EA202190201 A EA 202190201A EA 202190201 A1 EA202190201 A1 EA 202190201A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- methods
- tumor size
- application
- size reduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862695613P | 2018-07-09 | 2018-07-09 | |
PCT/US2019/040264 WO2020023191A1 (en) | 2018-07-09 | 2019-07-02 | Tumor reduction formulations and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202190201A1 true EA202190201A1 (ru) | 2021-04-09 |
Family
ID=75267393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202190201A EA202190201A1 (ru) | 2018-07-09 | 2019-07-02 | Составы для уменьшения размера опухоли и способы их применения |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3820482A4 (de) |
JP (1) | JP2021530482A (de) |
KR (1) | KR20220098082A (de) |
CN (1) | CN112584841A (de) |
AU (1) | AU2019309757A1 (de) |
BR (1) | BR112021000279A8 (de) |
CA (1) | CA3105717A1 (de) |
EA (1) | EA202190201A1 (de) |
IL (1) | IL280000A (de) |
PH (1) | PH12021550033A1 (de) |
WO (1) | WO2020023191A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA202193111A1 (ru) | 2019-05-14 | 2022-02-10 | Тайм, Инк. | Композиции и способы для лечения рака |
AU2020401131A1 (en) * | 2019-12-09 | 2022-07-14 | Tyme, Inc. | Pharmaceutical compositions and methods |
US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005209243A1 (en) * | 2004-01-29 | 2005-08-11 | Baxter Healthcare S.A. | Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
WO2006099685A1 (en) * | 2005-03-24 | 2006-09-28 | Medical Therapies Limited | Method for the prophylaxis or treatment of carcinomas |
CN101023940A (zh) * | 2006-02-20 | 2007-08-29 | 郝守祝 | 一种紫杉烷类化合物的药用组合物、制备方法及用途 |
EP3169707B1 (de) * | 2014-07-11 | 2020-12-02 | The Regents of the University of California | Tumorselektive makropinozytose-abhängige schnell internalisierende antikörper |
US9687528B2 (en) * | 2014-12-23 | 2017-06-27 | Steven Hoffman | Transdermal formulations |
CN109195601A (zh) * | 2016-03-15 | 2019-01-11 | 迪美公司 | 用于治疗癌症的药物组合物 |
-
2019
- 2019-07-02 AU AU2019309757A patent/AU2019309757A1/en not_active Abandoned
- 2019-07-02 CN CN201980054337.1A patent/CN112584841A/zh active Pending
- 2019-07-02 KR KR1020217003523A patent/KR20220098082A/ko active Search and Examination
- 2019-07-02 EP EP19841949.1A patent/EP3820482A4/de not_active Withdrawn
- 2019-07-02 CA CA3105717A patent/CA3105717A1/en active Pending
- 2019-07-02 WO PCT/US2019/040264 patent/WO2020023191A1/en unknown
- 2019-07-02 JP JP2021500520A patent/JP2021530482A/ja not_active Withdrawn
- 2019-07-02 BR BR112021000279A patent/BR112021000279A8/pt not_active Application Discontinuation
- 2019-07-02 EA EA202190201A patent/EA202190201A1/ru unknown
-
2021
- 2021-01-06 PH PH12021550033A patent/PH12021550033A1/en unknown
- 2021-01-07 IL IL280000A patent/IL280000A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112021000279A8 (pt) | 2021-04-20 |
KR20220098082A (ko) | 2022-07-11 |
AU2019309757A1 (en) | 2021-03-04 |
BR112021000279A2 (pt) | 2021-04-06 |
EP3820482A4 (de) | 2022-03-23 |
IL280000A (en) | 2021-03-01 |
CA3105717A1 (en) | 2020-01-30 |
JP2021530482A (ja) | 2021-11-11 |
EP3820482A1 (de) | 2021-05-19 |
CN112584841A8 (zh) | 2021-06-18 |
WO2020023191A1 (en) | 2020-01-30 |
PH12021550033A1 (en) | 2021-09-20 |
CN112584841A (zh) | 2021-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202092590A1 (ru) | Пиридазиноны в качестве ингибиторов parp7 | |
PH12020500240A1 (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
PH12018500714A1 (en) | Anti-tigit antigen-binding proteins and methods of use thereof | |
MX2018008052A (es) | Inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
MX2021006531A (es) | Composicion que contiene arn para tratamiento de enfermedades tumorales. | |
EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201791516A1 (ru) | Способы комбинированного лечения злокачественных опухолей | |
EA201890754A1 (ru) | Соединения и способы их применения | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201590997A1 (ru) | Соединения и способы их применения | |
PH12019502025A1 (en) | Anti-tigit antigen-binding proteins and methods of use thereof | |
EA201990296A1 (ru) | Антитела против siglec-7 для лечения рака | |
PH12019501405A1 (en) | Anti-neuropilin antigen-binding proteins and methods of use thereof | |
EA201890810A1 (ru) | Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение | |
EA202090183A1 (ru) | Композиции, способы и получение дейтерированного домперидона | |
EA202190201A1 (ru) | Составы для уменьшения размера опухоли и способы их применения | |
MX2017011521A (es) | Composiciones topicas que comprenden un corticosteroide. | |
EA201791174A1 (ru) | Антимикотическое соединение | |
MX2020003219A (es) | Anticuerpos que tienen especificidad para btn2 y usos de los mismos. | |
EA201890457A1 (ru) | Комбинации антитела против ox40 и модулятора tlr4 и их применение | |
EA201992318A1 (ru) | Композиции и способы для диагностики и лечения рака предстательной железы с использованием молекулы, связывающей прогастрин | |
EA201992315A1 (ru) | Композиции и способы для лечения рака легкого | |
EA201990978A1 (ru) | Антитела против pd-1 | |
EA201691896A1 (ru) | Соединения и способы их применения | |
EA201892376A1 (ru) | Комбинированный состав трех противовирусных соединений |